Key facts
- This page summarizes Daniel J. Hirsch's Form 4 filing for Envoy Medical, Inc. (COCH).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Oct 2023, 21:46.
Daniel J. Hirsch - 29 Sep 2023 Form 4 Insider Report for Envoy Medical, Inc. (COCH)
- Reporting relationship
- CFO and Corporate Secretary, Director
- Issuer ticker
- COCH
- Reported as of
- 29 Sep 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Oct 2023, 21:46:09 UTC
- Prior SEC filing
- 01 Sep 2023
- Next SEC filing
- 04 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Andrew P. Campbell as attorney-in-fact for Daniel J. Hirsch
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Daniel J. Hirsch filed Form 4 for Envoy Medical, Inc. (COCH) on 03 Oct 2023.
Change
- Previous filing in this sequence was filed on 01 Sep 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ANZU
transaction
Class A Common Stock, par value $0.0001 per share
Conversion of derivative security
- Transaction value
- $0
- Shares
- +25,000
- Change %
- Price
- $0.000000
- Shares after
- 25,000
- Date
- 29 Sep 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ANZU
transaction
Derivative
Class B Common Stock, par value $0.0001 per share
Conversion of derivative security
- Transaction value
- $0
- Shares
- -25,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 29 Sep 2023
- Ownership
- Direct
- Underlying class
- Class A Common Stock, par value $0.0001 per share
- Underlying amount
- 25,000
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Daniel J. Hirsch is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 1 footnote
Footnote F1
On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu.